Schlosser Michael J
EVP and Chief Clinical Officer
Schlosser Michael J has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Nov 6, 2026.
On the most recent filing, Schlosser Michael J is listed as EVP and Chief Clinical Officer at HCA Healthcare, Inc. Inside the rolling window, Schlosser Michael J reported no open-market purchases and 1 open-market sale totaling $594K in HCA.
Companies traded
Other insiders at HCA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$594K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Schlosser Michael J made?
Schlosser Michael J has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Schlosser Michael J trade?
Schlosser Michael J has filed SEC Form 4 disclosures for 1 company, including HCA.
When was Schlosser Michael J's most recent SEC Form 4 filing?
Schlosser Michael J's most recent SEC Form 4 filing on Tracefour is dated Nov 6, 2026.
What is Schlosser Michael J's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Schlosser Michael J is listed as EVP and Chief Clinical Officer.
What is Schlosser Michael J's total buy and sell value in the current window?
Inside the rolling retention window, Schlosser Michael J bought $0 and sold $594K based on SEC Form 4 filings.
What was Schlosser Michael J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,200 HCA shares on 2026-11-04, worth $594K, per SEC Form 4 filings.